跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
MEZERA
Authorized
STANDARD
MEZERA
avir pharma inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
22b81c7d271edc37
Company
avir pharma inc.
Type
Standard
Approval Details
Approval Id
22b81c7d271edc37
Drug Approval Canada Name
MEZERA
Product Name
MEZERA
Status
Marketed
Status Date
2022-10-05
Original Market Date
2022-10-05
Din
02524481
Drug Class
Human
Dosage Form
Tablet (Delayed-Release)
Route Of Administration
Oral
Schedule
Prescription
Ahfs
56:36.00
Atc Original
A07EC02 MESALAZINE
Atc Name
a 07 ec 02
Aig Number
0116808002
Company Name
avir pharma inc.
Company Address
660 Boulevard Industriel, Blainville, Quebec, Canada, J7C 3V4
Active Ingredients
MESALAZINE
500 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
22b81c7d271edc37
Type
Standard
Back to Health Canada Approvals
MEZERA - Health Canada Drug Approval Details